Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes

INTRODUCTION: Restless legs syndrome (RLS) affects 5–15% of adults, but is often unrecognized and consequently misdiagnosed. The International Restless Legs Scale (IRLS) has been developed and validated to assess the severity of RLS. Currently, the most common treatment for RLS is levodopa, but this...

Descripción completa

Detalles Bibliográficos
Autor principal: Winlow, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Outcomes Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321653/
https://www.ncbi.nlm.nih.gov/pubmed/22496675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321653/
https://www.ncbi.nlm.nih.gov/pubmed/22496675

Ejemplares similares